Malignant transformation of inflammatory myofibroblastic tumor of urinary bladder: A rare case scenario
Inflammatory myofibroblastic tumor (IMT) previously known as inflammatory pseudotumor, plasma cell granuloma, pseudosarcoma, myxoid hamartoma or inflammatory myofibrohistiocytic proliferation is recently recognized by World Health Organization (WHO) as “IMT” and is considered as a rare benign tumor of soft tissues occurring commonly in lung, liver and mesentry and omentum. IMT is mainly identified as a lesion of children and young population. In this report, we describe a rare case of IMT occurring in a 93-year-old female in urinary bladder with initial benign presentation but demonstrating rapid malignant transformation as confirmed with morphology and immunohistochemical (IHC) stains. Our report highlights the importance of close follow for IMT showing malignant transformation along with utility of IHC stains to evaluate the degree of malignant transformation in such cases.
1. Kim HW, Choi YH, Kang SM, Ku JY, Ahn JH et al. (2012) Malignant Inflammatory Myofibroblastic Tumor of the Bladder with Rapid Progression. Korean J Urol. 53: 657-661.
2. Weiss SW, Goldblum JR. (2008) Enzinger and Weiss's Soft Tissue Tumors; fifth edition. Mosby Elsevier Press. USA
3. Fletcher CD, Unni K, Mertens F (2002) Pathology and Genetics of Tumors of Soft Tissue and Bone. World Health Organization Classification of Tumors, IARC Press. France
4. Cantera JE, Alfaro MP, Rafart DC, Zalazar R, Muruzabal MM et al. (2015) Inflammatory myofibroblastic tumours: a pictorial review. Insights Imaging. 6: 85-96.
5. Inflammatory Myofibroblastic Tumor of the Bladder. Alderman M, Kunju LP (2014) Arch Pathol Lab Med. 138: 1272–1277.
6. Roth JA (1980) Reactive pseudosarcomatous response in urinary bladder. Urology. 16: 635-637.
7. Montgomery EA, Shuster DD, Burkart AL, Esteban JM, Sgrignoli A et al. (2006) Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Am J Surg Pathol. 30:1502-1512.
8. Cao Z, Gao Q, Fu M, Ni N, Pei Y et al. (2019) Anaplastic lymphoma kinase fusions: Roles in cancer and therapeutic perspectives. Oncol Lett. 17: 2020-2030.
9. Taylor MS, Chougule A, MacLeay AR, Kurzawa P, Chebib I et al. (2019) Morphologic Overlap Between Inflammatory Myofibroblastic Tumor and IgG4-related Disease: Lessons From Next-generation Sequencing. Am J Surg Pathol. 43 :314-324.
10. Silva DC, Gonçalves AK, Cobucci RN, Mendonça RC, Lima PH et al. (2017) Immunohistochemical expression of p16, Ki-67 and p53 in cervical lesions - A systematic review. Pathol Res Pract. 213: 723-729.